/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Rx/Medicines

Topic

Latest Stories

Get It Covered
3.10.24, 12:00 PM EDT on neoscope
Wegovy Approved to Cut Heart Disease and Stroke Risk
Compounding Factors
3.2.24, 6:30 AM EST on neoscope
Woman Takes Grey Market Ozempic, Lands in Hospital
Market Sharing
2.22.24, 4:32 PM EST on neoscope
Indian Drugmakers Whipping Up Generic Versions of Wegovy
Crisis Aversion
2.1.24, 9:02 AM EST on neoscope
New Non-Opioid Drug Blocks Pain Signals Before They Can Reach Brain
Pill Mill
1.25.24, 11:18 AM EST on neoscope
Unregulated White House Pharmacy Gave Out Uppers and Downers to Senior Staff Under Trump
Low Risk
1.12.24, 9:08 AM EST on neoscope
The FDA Says Ozempic Probably Won't Make You Suicidal
Gains and Losses
1.4.24, 11:52 AM EST on neoscope
Semaglutide Patients Regained More Weight Than They’d Lost After Stopping Their Injections
OD
12.20.23, 2:17 PM EST on neoscope
Thousands of People Have Reportedly Overdosed on Ozempic
Losing It
12.2.23, 7:30 AM EST on neoscope
Pfizer Cancels New Weight Loss Pill After Patients Experience Serious Side Effects
Losses and Gains
10.12.23, 10:37 AM EDT on neoscope
Woman Sues to Get Wegovy Covered by Her Health Insurance
Wally World
10.8.23, 6:30 AM EDT on neoscope
Walmart Spies on Ozempic Patients' Shopping Habits, Finds They're Buying Less Food
Snacko Killer
10.6.23, 10:35 AM EDT on neoscope
Snack Food Investors Concerned About the Rise of Semaglutide
  • Previous
  • 1
  • ...
  • 5
  • 6
  • 7
  • ...
  • 19
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.